Cirurgia Bariátrica
Estudo de coorte | Em pacientes submetidos a cirurgia bariátrica, aqueles que fizeram bypass gástrico foram levemente mais propensos a se manter sem medicamentos relacionados com obesidade durante o seguimento, em comparação com aqueles que fizeram gastroplastia vertical.
20 Jan, 2022 | 21:01hMedication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass – JAMA Surgery (link para o resumo – $ para o texto completo)
Comentário: Gastric Bypass Tied to Modest Shift in Need for Comorbidity Meds – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Among patients taking medications for obesity-related conditions before bariatric surgery, gastric bypass and sleeve gastrectomy both had high rates of medication discontinuation after surgery, however gastric bypass was slightly more effective. https://t.co/JrIaYk9dZT pic.twitter.com/BAbaGINCpb
— JAMA Surgery (@JAMASurgery) January 12, 2022
Diretrizes ERAS para atenção perioperatória na cirurgia bariátrica.
20 Jan, 2022 | 20:02hConteúdo relacionado: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Comentário no Twitter
#VisualAbstract ➡️ Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update@Jasosamd @iss_sic
🆓🔗https://t.co/HknWwLUjCZ pic.twitter.com/amhszadwup— WJS (@WorldJSurg) January 5, 2022
Estudo de coorte | Pacientes que perderam peso via cirurgia bariátrica podem estar sob menor risco de ter Covid-19 grave, em comparação a pacientes não submetidos a intervenção cirúrgica como tratamento de sua obesidade.
17 Jan, 2022 | 13:11hComentários:
Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery? – JAMA Surgery
Can weight loss help protect against Covid-19? – CNN
Estudo randomizado | Balão intragástrico ajustável resultou em perda significativa de peso em 32 semanas, mas a intolerância levou à remoção precoce do dispositivo em 17% dos pacientes, e eventos adversos graves relacionados ao dispositivo foram observados em 4% dos pacientes.
17 Nov, 2021 | 12:52hAdjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário no Twitter
In this trial, when an adjustable intragastric balloon was combined with lifestyle modification in adults with obesity, significant weight loss was achieved and maintained for 6 months following device removal. https://t.co/jg7z5ldeC7 #GITwitter pic.twitter.com/Pi9PVAeWzo
— The Lancet (@TheLancet) November 16, 2021
Estudo de coorte | Em pacientes com esteato-hepatite não alcoólica e obesidade, a cirurgia bariátrica foi associada com menor risco de incidência de desfechos adversos hepáticos maiores e eventos cardiovasculares maiores.
12 Nov, 2021 | 13:33hAssociation of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (gratuito por tempo limitado)
Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (gratuito por tempo limitado)
Comentário no Twitter
Study found, among patients with nonalcoholic steatohepatitis and obesity, bariatric surgery, vs nonsurgical management, was associated with a significantly lower risk of incident major adverse liver outcomes and major adverse cardiovascular events https://t.co/Ps23yfjncq
— JAMA (@JAMA_current) November 11, 2021
Amplo estudo observacional sugere que a gastrectomia vertical pode ser mais segura se comparada ao bypass gástrico em pacientes com obesidade grave.
8 Out, 2021 | 11:43hComparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity – JAMA Surgery (gratuito por tempo limitado)
Comentários:
Compared to What?—Novel Methods to Approach Randomization for Long-term Bariatric Surgery Outcomes – JAMA Surgery (gratuito por tempo limitado)
Of two common weight loss surgeries, one is safer but less effective – Michigan Medicine
Conteúdos relacionados:
Cohort study: comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass
Cohort study: interventions and operations 5 years after bariatric surgery
Randomized trial: gastric bypass superior to sleeve gastrectomy for remission of type 2 diabetes
Research: laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass
Comentário no Twitter
Study suggests that the safety benefits of sleeve gastrectomy persist up to 5 years after surgery; this information may help patients and surgeons make informed treatment decisions https://t.co/JuRQGh3byz
— JAMA Surgery (@JAMASurgery) October 6, 2021
Diferentes riscos e benefícios levam a custos similares após gastroplastia vertical e bypass gástrico em Y de Roux.
12 Set, 2021 | 22:01hEstudo original: Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy – JAMA Network Open
Comentário no Twitter
Cohort study found that 4-year healthcare expenditures associated with Roux-en-Y gastric bypass (RYGB) surgery and sleeve gastrectomy (SG) did not differ in Ontario, Canada. https://t.co/pegVdcwgJG
— JAMA Network Open (@JAMANetworkOpen) September 9, 2021
Atualização de prática clínica da AGA sobre avaliação e tratamento de complicações iniciais após cirurgia bariátrica/metabólica.
24 Ago, 2021 | 11:40h
Comentário no Twitter
August's Essential Reading article is a Clinical Practice Update on evaluation and management of early complications after bariatric/metabolic surgery @AmerGastroAssn https://t.co/mm8qSkR95y pic.twitter.com/6vsI3qGv2I
— CGH (@AGA_CGH) July 28, 2021
Podcast | Cirurgia bariátrica para o clínico – Seleção do paciente, conduta perioperatória e cuidado pós-operatório.
25 Mai, 2021 | 15:44h#275 Bariatric Surgery for the Internist with Dr. Vivian Sanchez – The Curbsiders